(Q62110085)
Statements
Risk Adapted Intravenous Melphalan and Adjuvant Thalidomide and Dexamethasone for Untreated Patients With Primary Systemic Amyloidosis (English)
0 references
May 2002
0 references
December 2007
0 references
clinical trial